Fowler John Franklin 4
4 · Kezar Life Sciences, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
Fowler John Franklin
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-14+5,000→ 5,000 totalExercise: $5.89Exp: 2035-02-13→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]One-hundred percent (100%) of the shares subject to the option shall vest on February 1, 2026, subject to Reporting Person continuing to provide service through such date.